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Examining a potential functional role for growth hormone secretagogue receptors in the hippocampus, Diano and col-
leagues (Diano et al., 2006), demonstrate novel actions of the orexigenic peptide ghrelin in hippocampal synaptic architec-
ture, LTP, and learning and memory. These data suggest functional links between metabolic signaling and higher neural
function.Animals have been shown to adopt food-
searching strategies appropriate to their
environment, switching sites when multi-
ple low-density food sources are avail-
able but returning to sites with abundant
food. The ability to locate food sources,
remember those locations, and recall
whether or not all the available food was
consumed are important survival skills.
Energy would not be wasted looking in
low-probability sites or returning to sites
where all the food had already been
eaten. Is the ability to do this in any way
tied to signaling molecules critical to en-
ergy balance? Recent work by Diano and
colleagues (Diano et al., 2006) demon-
strating that ghrelin, a feeding-related
peptide, also plays a role in modulating
hippocampal synaptic architecture, sug-
gests just such a relationship.
Ghrelin, the endogenous ligand for the
growth hormone secretagogue (GHS) re-
ceptor, is primarily synthesized in the
stomach and upper intestine (Kojima
et al., 1999). A role for ghrelin in the
control of food intake has been de-
monstrated (Tschop et al., 2000). Both
peripheral and central ghrelin administra-
tion increase eating and do so by de-
creasing the latency to begin to eat
and increasing the number of meals con-
sumed (Faulconbridge et al., 2003). Such
data have led to the suggestion that en-
dogenous ghrelin acts as a hunger sig-
nal. Consistent with such a role, plasma
ghrelin levels are under multiple meta-
bolic controls. Levels rise with food dep-
rivation, peaking prior to meals, and are
decreased in response to eating. Ghrelin
levels are also upregulated with weight
loss, suggesting that ghrelin is not only
involved in the meal-to-meal control of
food intake but also plays a role in overall
energy balance (Cummings et al., 2002).
The major site of action for ghrelin-
induced feeding has been postulated to
be the basal hypothalmus. GHS recep-
tors have been localized to neuropeptide
Y (NPY)-expressing neurons in the arcu-
ate nucleus, and ghrelin has been shown
to activate these neurons (Cowley et al.,CELL METABOLISM : APRIL 20062003). Thus, in the hypothalamus, ghrelin
and the adiposity hormone leptin have
opposing effects (Figure 1). Leptin re-
duces orexigenic signaling, downregu-
lating the expression of the feeding-stim-
ulatory peptides NPY and agouti-related
peptide (AgRP) and increasing anorexi-
genic signaling by activating proopiome-
lanocortin (POMC) expression and in-
creasing the release of a2MSH. Such
changes in hypothalamic signaling inhibit
eating. In contrast, ghrelin increases NPY
and AgRP and decreases POMC expres-
sion, changes that stimulate food intake.
Leptin and ghrelin have also been shown
to have opposite effects on synaptic ar-
chitecture within the arcuate nucleus.
Leptin alters the number of excitatory
and inhibitory synapses onto NPY and
POMC expressing neurons (Pinto et al.,
2004). Leptin increases the number of in-
hibitory inputs and decreases the num-
ber of excitatory inputs onto NPY neu-
rons. Leptin also increases the number
of excitatory inputs onto POMC neurons.
Such results alter the balance of activity
so that with leptin treatment, there are in-
creased excitatory postsynaptic currents
(EPSC) to POMC neurons and increased
inhibitory postsynaptic current (IPSC) to
NPY neurons, biasing toward POMC ac-
tivation and NPY inhibition or increasing
anorexigenic and decreasing orexigenic
signaling. Ghrelin administration has the
opposite effects, decreasing the number
of excitatory inputs and increasing the
number to inhibitory inputs to POMC
neurons, a change consistent with
ghrelin’s orexigenic actions.
Based on the distribution of GSH re-
ceptors, Diano and colleagues (Diano
et al., 2006) investigated a potential role
for ghrelin in hippocampal function.
They demonstrated ghrelin binding in
the hippocampus, localized primarily
to the processes of hippocampal neu-
rons. The distribution of bindingwas con-
sistent with the immunohistochemical
localization of GSH receptors. Impor-
tantly, they demonstrated that peripheral
ghrelin has access to hippocampal sitesand that ghrelin uptake in the hippocam-
pus was occurring through a saturable
process.
Using electron microscopy, they went
on to demonstrate that peripheral ghrelin
administration, at a dose that had a mod-
est effect on food intake, resulted in a
significant increase in spine synaptic
density in the CA1 subregion of the hip-
pocampus. They also demonstrated a
role for endogenous ghrelin in hippocam-
pal architecture. Ghrelin knockout mice
had significantly fewer dendritic spines
than wild-type controls, and exogenous
ghrelin administration in the knockouts
resulted in a normalization of CA1 spine
density.
The functional significance of in-
creased spine density was assessed
both electrophysiologically and behav-
iorally. Ghrelin promoted long-term po-
tentiation (LTP) in hippocampal slices
and improved performance in a number
of learning and memory tasks. Using a
spontaneous alternation plus maze task,
a paradigm with demonstrated hippo-
campal dependence, peripheral ghrelin
or a ghrelin agonist administration re-
sulted in marked improvements of alter-
nation performance, without affecting
overall locomotor acitivty. Central ghrelin
administration was also demonstrated to
increase retention in foot shock avoid-
ance tasks, and improve performance in
aged mice. Finally, they demonstrated
a role for endogenous ghrelin by showing
that ghrelin-deficient mice had a deficit in
a novel object recognition task, a deficit
that could be reversed by exogenous
ghrelin administration.
An interesting aspect of these findings
is that although ghrelin and leptin have
opposing effects in the basal hypothala-
mus, they appear to have similar func-
tional actions in the hippocampus. Leptin
has been shown to enhance hippocam-
pal LTP through a mechanism involving
facilitation of NMDA receptor function
(Shanley et al., 2001). Obese, leptin-defi-
cient rodents demonstrate impairments
in hippocampla LTP and long-term233
P R E V I E W SFigure 1. Central actions of ghrelin and leptin
Although ghrelin and leptin have opposing actions on hypothalamic architecture, hypothalamic peptide signal-
ing, and feeding, they have similar actions in the hippocampus. Both peptides increase hippocampal synaptic
density and improved performance in tests of learning and memory. Diano et al. (2006) demonstrate that cir-
culating ghrelin crosses the blood brain barrier and binds to GHS receptors on hippocampal neurons, leading
to increased dendritic spine synapse formation, long-term potentiation, and enhanced spatial learning and
memory. The figure depicts a cross section of the brain and the actions of ghrelin and leptin in the specified
brain regions.depression (LDP) and evidence deficits in
performance in a Morris water maze task
consistent with impaired spatial memory
(Li et al., 2002). Similar to findings of
Diano et al. (2006), administration of ex-
ogenous leptin directly to the hippocam-
pus has recently been shown to improve
retention in shock avoidance tasks and
improve performance in aged mice (Farr
et al., 2005).
Why peptides with opposing actions in
feeding should have similar effects on
substrates for learning and memory is
not clear. Ghrelin levels are high prior to
feeding, a time at which food seeking oc-
curs. Elevated ghrelin levels in that con-
text may facilitate learning about food
sources. Plasma leptin levels are posi-
tively associated with adiposity and de-
cline with food deprivation. Decreased
ghrelin and leptin signaling with aging
and obesity are consistent with cognitive
decline associated with those states.
Both obesity and aging are associated
with leptin insensitivity and both states234are associated with decreased plasma
ghrelin levels. The multiple functions of
peripheral peptides with demonstrated
roles in energy balance may complicate
their use as targets for either weight con-
trol of cognitive enhancement.
The demonstrations of ghrelin trans-
port into the brain and of ghrelin actions
outside the hypothalamus open up the
possibility that changes in plasma ghrelin
levels in response to eating and food
deprivation may be affecting multiple
brain sites and multiple functions. GHS
receptors are widely distributed in brain.
Given the interactions between ghrelin
and leptin in hypothalamus and hippo-
campus, additional candidate sites of ac-
tions and functions for ghrelin may best
be identified based on known actions of
leptin in brain. For example, leptin has
been shown to affect dopaminergic ac-
tivity in the ventral tegmental area (VTA),
an action that has been associated with
modulation of reward (Figlewicz et al.,
2003). Localization of GHS receptormRNA in the VTA suggests this as an-
other site of potential leptin/ghrelin inter-
action. Much work remains, but data
such as those of Diano et al. (2006) com-
pel a broader perspective on where mol-
ecules tied to energy balance function
and how they may exert their effects.
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